Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct;61(10):1218-1224.
doi: 10.1111/ijd.16070. Epub 2022 Jan 26.

Risk factors and prevention strategies for cutaneous squamous cell carcinoma in transplant recipients

Brittany Urso  1 , Andrew Kelsey  2 , Jenna Bordelon  3 , Patricia Sheiner  4 , Justin Finch  2   5 , Joel L Cohen  1   6
Affiliations
Review

Risk factors and prevention strategies for cutaneous squamous cell carcinoma in transplant recipients

Brittany Urso et al. Int J Dermatol. 2022 Oct.

Abstract

It has been well established that organ transplant recipients (OTRs) are at an increased risk of skin cancer. Studies vary on the exact degree of this risk, but it is likely somewhere between 60 and 100 times more likely that an OTR patient will develop skin cancer. The management of skin cancer burden in OTRs requires a multidisciplinary approach with the transplant team, dermatologists, and oncology. In many major hospital systems, there are dedicated transplant dermatology clinics that allow for specialized and more frequent screenings of this high-risk population. Here we discuss the pathogenesis, presentation, and treatment options used by dermatologists to prevent and treat commonly found skin cancers in this vulnerable population.

PubMed Disclaimer

References

    1. O'Reilly Zwald F, Brown M. Skin cancer in solid organ transplant recipients: advances in therapy and management: part II. Management of skin cancer in solid organ transplant recipients. J Am Acad Dermatol 2011; 65: 253-261.
    1. Muehleisen B, Jiang SB, Gladsjo JA, et al. Distinct innate immune gene expression profiles in non-melanoma skin cancer of immunocompetent and immunosuppressed patients. PLoS One 2012; 7: 1-12.
    1. Crow LD, Jambusaria-Pahlajani A, Chung CL, et al. Initial skin cancer screening for solid organ transplant recipients in the United States: Delphi method development of expert consensus guidelines. Transpl Int 2019; 32: 1268-1276.
    1. Sheil A, Disney A, Mathew T, et al. De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation. Transpl Proc 1993; 25: 1383-1384.
    1. Mittal A, Colegio OR. Skin cancers in organ transplant recipients. Am J Transplant 2017; 17: 2509-2530.

MeSH terms

LinkOut - more resources